|
119
|
356
|
9azwA |
Crystal structure of pdc-88 beta-lactamase in complex with taniborbactam |
|
129
|
359
|
9azuA |
Crystal structure of pdc-3 beta-lactamase in complex with taniborbactam |
|
94
|
263
|
8g2rA |
Crystal structure of the kpc-2 d179n variant in complex with avibactam |
|
78
|
251
|
7ss6A |
Structure of klebsiella lpxh in complex with jh-lph-45 |
|
79
|
247
|
7ss7A |
Crystal structure of klebsiella lpxh in complex with jh-lph-50 |
|
91
|
264
|
7lr9A |
Crystal structure of kpc-2 s70g/t215p mutant with hydrolyzed imipenem |
|
90
|
264
|
7lnlA |
Crystal structure of kpc-2 s70g/t215p mutant with hydrolyzed imipenem |
|
86
|
260
|
7llhA |
Kpc-2 f72y mutant with acylated imipenem |
|
97
|
266
|
6xd7A |
Kpc-2 n170a mutant bound to hydrolyzed ampicillin at 1.65 a |
|
84
|
240
|
6ol8A |
Crystal structure of ndm-12 metallo-beta-lactamase in complex with hydrolyzed ampicillin |
|
106
|
324
|
6vbdA |
Crystal structure of transpeptidase domain of pbp2 from neisseria gonorrhoeae cephalosporin-resistant strain h041 acylated by ceftriaxone |
|
63
|
178
|
6vgnH |
Clpp1p2 complex from m. tuberculosis bound to adep |
|
68
|
196
|
6vgnA |
Clpp1p2 complex from m. tuberculosis bound to adep |
|
94
|
277
|
6nvuA |
Crystal structure of tla-1 extended spectrum beta-lactamase in complex with clavulanic acid |
|
69
|
192
|
6pmdA |
Structure of clpp from staphylococcus aureus in complex with acyldepsipeptide |
|
69
|
189
|
6pkaA |
Structure of clpp from staphylococcus aureus in complex with ureadepsipeptide |
|
90
|
242
|
6p99A |
Oxa-48 carbapanemase, ertapenem complex |
|
86
|
242
|
6p9cA |
Oxa-48 carbapanemase, doripenem complex |
|
89
|
245
|
6p98A |
Oxa-48 carbapanemase, meropenem complex |
|
108
|
326
|
6p55A |
Crystal structure of transpeptidase domain of pbp2 from neisseria gonorrhoeae acylated by cefixime |
|
105
|
325
|
6p54A |
Crystal structure of transpeptidase domain of pbp2 from neisseria gonorrhoeae acylated by ceftriaxone |
|
69
|
189
|
5w18A |
Staphylococcus aureus clpp in complex with (s)-n-((2r,6s,8as,14as,20s,23as)-2,6-dimethyl-5,8,14,19,23-pentaoxooctadecahydro-1h,5h,14h,19h-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1]oxa[4,7,10,13]tetraazacyclohexadecin-20-yl)-3-phenyl-2-(3-phenylureido)propanamide |
|
0
|
5
|
5w18H |
Staphylococcus aureus clpp in complex with (s)-n-((2r,6s,8as,14as,20s,23as)-2,6-dimethyl-5,8,14,19,23-pentaoxooctadecahydro-1h,5h,14h,19h-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1]oxa[4,7,10,13]tetraazacyclohexadecin-20-yl)-3-phenyl-2-(3-phenylureido)propanamide |
|
69
|
192
|
3mt6A |
Structure of clpp from escherichia coli in complex with adep1 |
|
96
|
260
|
6cyqA |
Crystal structure of ctx-m-14 s70g/n106s beta-lactamase in complex with hydrolyzed cefotaxime |
|
93
|
261
|
6cyuA |
Crystal structure of ctx-m-14 s70g/n106s/d240g beta-lactamase in complex with hydrolyzed cefotaxime |
|
109
|
367
|
6ntzA |
Crystal structure of e. coli pbp5-meropenem |
|
186
|
557
|
6g9sA |
Structural basis for the inhibition of e. coli pbp2 |
|
178
|
557
|
6g9pA |
Structural basis for the inhibition of e. coli pbp2 |
|
182
|
557
|
6g9fA |
Structural basis for the inhibition of e. coli pbp2 |
|
47
|
245
|
3s04A |
Crystal structure of escherichia coli type i signal peptidase in complex with an arylomycin lipoglycopeptide antibiotic |
|
77
|
233
|
5n0hA |
Crystal structure of ndm-1 in complex with hydrolyzed meropenem - new refinement |
|
29
|
157
|
5lp5C |
Complex between penicillin-binding protein (pbp2) and mrec from helicobacter pylori |
|
157
|
548
|
5lp5A |
Complex between penicillin-binding protein (pbp2) and mrec from helicobacter pylori |
|
80
|
239
|
5l2fA |
High resolution structure of acinetobacter baumannii beta-lactamase oxa-51 i129l/k83d bound to doripenem |
|
110
|
336
|
5k99A |
Crystal structure of microcin immunity protein mccf from bacillus anthracis in complex with mcc |
|
54
|
172
|
6ck7A |
Crystal structure of a peptide deformylase from legionella pneumophila bound to actinonin |
|
69
|
188
|
6cfdA |
Adep4 bound to e. faecium clpp |
|
87
|
265
|
6b6aA |
Beta-lactamase, 2secs timepoint, mixed, shards crystal form |
|
88
|
265
|
6b6eA |
Beta-lactamase, mixed with ceftriaxone, needles crystal form, 500ms |
|
81
|
265
|
6b6fA |
Beta-lactamase, mixed with ceftriaxone, needles crystal form, 2sec |
|
88
|
265
|
6b6cA |
Beta-lactamase, mixed with ceftriaxone, needles crystal form, 30ms |
|
85
|
265
|
6b6dA |
Beta-lactamase, mixed with ceftriaxone, needles crystal form, 100ms |
|
88
|
265
|
6b68A |
Beta-lactamase, 100ms timepoint, mixed, shards crystal form |
|
89
|
265
|
6b69A |
Beta-lactamase, 500ms timepoint, mixed, shards crystal form |
|
79
|
241
|
5zgqA |
Crystal structure of ndm-1 at ph7.5 (tris-hcl, (nh4)2so4) in complex with hydrolyzed ampicillin |
|
85
|
241
|
5zgeA |
Crystal structure of ndm-1 at ph5.5 (bis-tris) in complex with hydrolyzed ampicillin |
|
82
|
241
|
5zgpA |
Crystal structure of ndm-1 at ph6.2 (bis-tris) in complex with hydrolyzed ampicillin |
|
83
|
242
|
5zgrA |
Crystal structure of ndm-1 at ph7.3 (hepes) in complex with hydrolyzed ampicillin |
|
70
|
189
|
5vz2A |
Structure of clpp from staphylococcus aureus in complex with acyldepsipeptide |
